# A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients

> **NCT00494611** · PHASE1 · TERMINATED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 25 (estimated)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Peri operative Cetuximab.

## Key facts

- **NCT ID:** NCT00494611
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 25 (ESTIMATED)
- **Why stopped:** Unable to recruit subjects in timely fashion for the study
- **Last updated:** 2011-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00494611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00494611, "A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00494611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*